Prevalence of rubella IgG antibodies among Syrian females of childbearing age

Saudi Medical Journal

Volumn 31, Issue 1, 2010, Pages 78-81

  Barah, Faraj A ^a   Chehada, Amer G ^a  

^a University of Kalamoon   (Syrian Arab Republic)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; RUBELLA VACCINE; IMMUNOGLOBULIN G; RUBELLA ANTIBODIES; VIRUS ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PREGNANCY; QUANTITATIVE ANALYSIS; RUBELLA; RUBELLA VIRUS; SEROLOGY; SYRIAN ARAB REPUBLIC; VACCINATION; ADOLESCENT; BLOOD; EPIDEMIOLOGY; IMMUNOLOGY; PREVALENCE;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; PREVALENCE; RUBELLA; SEROEPIDEMIOLOGIC STUDIES; SYRIA; YOUNG ADULT;

EID: 77949347029     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Gershon AA. German Measles. In: Mandell, Douglas, and Bennett's Principle and practice of infectious diseases. USA: Elsevier; 2005. p. 1921-1926.
2. Banatvala JE, Brown DW. Rubella. Lancet 2004; 363: 1127-1137.
3. WHO. Rubella vaccines. WHO position paper. Wkly Epidemiol Rec 2000; 75: 161-1672.
4. Reef SE, Frey TK, Theall K, Abernathy E, Burnett CL, Icenogle J, et al. The changing epidemiology of rubella in the 1990s: on the verge of elimination and new challenges for control and prevention JAMA 2002; 287: 464-472.
5. Bullens D, Smets K, Vanhaesebrouck P. Congenital rubella syndrome after maternal reinfection. Clin Pediatr (Phila) 2000; 39: 113-116.
6. Miller CL. Rubella in the developing world. Epidemiol Infect 1991; 107: 63-68.
7. World Health Organization. Immunization-monitoring data, world immunization summary. Geneva: WHO; 2008.
8. WHO. Vaccine-preventable diseases: monitoring system 2008 global summary.Geneva: WHO; 2008.
9. Communicable disease quarterly report: Immediately reported disease. Syrian Epidemiological Bulletin 2009. p. 3.
10. Centers for Disease Control and Prevention. Control and prevention of rubella: evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MorbMortal Wkly Rep 2001; 50: 1-30.
11. Lee JY, Bowden DS. Rubella virus replication and links to teratogenicity. Clin Microbiol Rev 2000; 13: 571-587.
12. United Nations. World population prospects, the 2006 revision. New York (NY): United Nations; 2007.
13. Witte JJ, Karchmer AW, Case G, Herrmann KL, Abrutyn E, Kassanoff I, et al. Epidemiology of rubella. Am J Dis Child 1969; 118: 107-111.
14. Yuan CF, Ng HT. Seroepidemiologic study of rubella in Taiwan's female population. Am J Public Health 1988; 78: 1366-1367.
15. Aksit S, Egemen A, Ozacar T, Kurugol Z, Keskinoglu P, Tasbakan M, et al. Rubella seroprevalence in an unvaccinated population in Izmir: recommendations for rubella vaccination in Turkey. Pediatr Infect Dis J 1999; 18: 577-580.
16. Monem, F. Use of Hemagglutination Inhibition Assay in an Evaluation of IgG Antibodies against Rubella Virus in School-Going Girls and Child-Bearing Age Women in Damascus, Syria. Arab J Pharm Sci 2001; 10: 35-46.
17. Kharath N. The MMR vaccination campaign in autumn 2008 in Syria. Syria: Syrian Epidemiological Bulletin; 2008. p. 2.
18. Panagiotopoulos T, Antoniadou I, Valassi-Adam E. Increase in congenital Rubella occurrence after immunization in Greece: retrospective survey and systematic review. Br Med J 1999; 319: 1462-1467.